Disclosures. Beyond BMD: Bone Quality & Bone Strength. Design of a Structure. Fractures = structural failure of the skeleton
|
|
- Maurice Glenn
- 5 years ago
- Views:
Transcription
1 Disclosures Beyond BMD: Bone Quality & Bone Strength Mary L. Bouxsein, PhD Center for Advanced Orthopedic Studies, BIDMC Department of Orthopedic Surgery, HMS MIT-Harvard Health Sciences and Technology Program Advisory board: Merck, Eli Lilly, Radius Consultant: Agnovos, Acceleron Pharma Research funding: Merck, Amgen Fractures = structural failure of the skeleton Design of a Structure Consider what loads it must sustain Design options Overall geometry Building materials Architectural details 1
2 Determinants of whole bone strength Basic bone biomechanics Quantity size and mass (BMD) Distribution shape or geometry cortical : trabecular mass microstructure Properties of Bone Matrix mineralization collagen microdamage others Force (N) Stiffness (slope) Structural Properties (extrinsic) Energy Displacement (mm) Maximum Load Stress Elastic modulus Toughness Strain Material Properties (intrinsic) Ultimate Stress Mechanical behavior of bone tissue and its constituents It is not really practical to do three point bending on a patient. Mineral Force (Stress) Bone Collagen Deformation (Strain) Slide courtesy of Paul Hansma, PhD 2
3 Clinical assessment of bone (strength) today BMD explains > 7% of whole bone strength in ex vivo human cadaver studies Areal BMD by DXA Bone mass / area (g/cm 2 ) Reflects (indirectly) Bone size Mineralization of matrix Strong predictor of fracture risk in untreated women (Marshall et al, 1996) Misses many who fracture Neglects many structural aspects of bone strength Femoral Strength (N) Proximal Femur (sideways fall) r 2 = Femoral Neck BMD (g/cm 2 ) Roberts et al, 21 Vertebral Strength (lbs) Bouxsein 1999 Vertebral body (L2) (compression + forward flexion) 6 r 2 = Spine BMD (g/cm 2 ) Moro et al, CTI, 1995 TBS associated with fractures, weakly with BMD TBS enhances 1-yr prediction of fx risk 29,47 postmenopausal women; 1668 (5.6%) had major OP frx Weak correlation to BMD: r = Incident fracture (per 1 person-yr) (FRAX) Hans et al JBMR 211 Leslie et al Osteop Int 214 3
4 Meta-analysis of TBS and Fracture >17, subjects in 14 studies (59% women) 298 hip fx and 119 major osteoporotic fx TBS changes following ALN or TPTD treatment in GIO TPTD abmd TBS associated with fracture independent of age, and FRAX (HR ~ 1.28 to 1.5) ALN abmd TPTD TBS ALN TBS McCloskey et al, JBMR 216 Saag et al, Arthritis and Rheum 216 DXA-based methods QCT HR-pQCT Finite Element Analysis Reference point indentation QCT ~3-5 µm voxel size Trabecular & cortical bone density, geometry Axial and appendicular skeleton Associated with fracture Less sensitive to soft tissue variability than DXA Novel applications Limited micro-structure Few prospective fx studies No standard analysis Lack of reference data Radiation exposure? Engelke et al, Curr OP Report 213 4
5 QCT-based femoral neck measures and hip fracture risk Hazard ratios per SD reduction All models adjusted for age, BMI, race, clinic site 3347 men > 65 yrs, 42 incident hip fx QCT-based femoral neck measures and hip fracture risk Hazard ratios per SD reduction All models adjusted for age, BMI, race, clinic site 3347 men > 65 yrs, 42 incident hip fx QCT HR per SD % cortical volume 3.4 ( ) Fem Neck area (cm 2 ) 1.6 ( ) Trab vbmd (g/cm 3 ) 1.6 ( ) QCT QCT + DXA HR per SD HR per SD % cortical volume 3.4 ( ) 2.5 ( ) Fem Neck area (cm 2 ) 1.6 ( ) 1.5 (1.1 2.) Trab vbmd (g/cm 3 ) 1.6 ( ) 1.2 (.8 1.9) Fem Neck abmd (g/cm 2 ) 2.1 ( ) Black, Bouxsein et al, JBMR 28 Black, Bouxsein et al, JBMR 28 QCT for Monitoring Treatment Response: Changes in Spine Bone Density by DXA and QCT: the PaTH trial Cortical thickness mapping to identify local osteoporosis Mean Change (%) abmd by DXA vbmd by QCT (Trabecular) PTH PTH/ALN ALN Black et al, NEJM, 23 Poole et al, PLoS ONE, 211 5
6 HR-pQCT DXA-based methods QCT, HR-QCT HR-pQCT Finite Element Analysis Reference point indentation 82 µm voxel size Peripheral skeleton only < 3 µsv Separation of cortical and trabecular compartments HR-pQCT discriminates osteopenic women with and without history of fragility fracture (age = 69 yrs, n=35 with prev frx, n=78 without fracture) Fracture vs No Fracture, % Difference BMD Spine Femoral Neck Boutroy et al, JCEM (25) HR-pQCT at the Radius BV/TV TbN TbTh TbSp TbSpSD * * * p <.5 vs fracture free controls * * 6
7 Distal Tibia Osteopenic by DXA BMD (7 yr old woman) Worse bone architecture in premenopausal women with distal radius fracture (4 premenopausal wrist fx, 8 age-matched controls) * P <.5 * P <.5 UDR adj * Wrist Frx Distal Radius Fx - Cont (%) DXA HR-pQCT * Control * * Rozental, Bouxsein et al, JBJS (213) Race-related differences in microarchitecture Pathophysiology of fragility in Type 2 Diabetes? Control Diabetes Diabetes + Frx T2DM have same or higher BMD, but markedly higher (+36 to 12%) cortical porosity vs non-diabetic controls Putman, Yu et al, JBMR 213 Burghardt et al, J Clin Endo Metab (21) 7
8 DXA-based methods 3D geometry QCT HR-pQCT Finite Element Analysis Ultimate Strength material properties Reference point indentation QCT Density Crawford, et al, Bone 23 Hip and spine FEA (ON Diagnostics) Approved by FDA in 212 Diagnosis of fragile bone, BMD t-score, monitoring Image courtesy of T. Keaveny Finite element analysis in clinical practice Clinical Translation Experimentally measured femoral strength vs FEA-predicted strength (sideways fall, 73 human femora, aged 55 to 98 yrs) Femoral Failure Load (N) r 2 =.78 p <.1 SEE = 9 N Women Men FEA-Predicted Femoral Strength (N) Bouxsein 1999 Fidler Radiology 215 8
9 QCT-based FEA vs femoral BMD for prediction of hip fracture CT procedures amenable to bone strength evaluation - CT colonography, CT Enterography Fem Neck BMD Hazard Ratio (95% CI)* QCT-FEA strength Older men (Mr OS) 1 4 hip fx vs 21 controls 4.4 ( ) 6.5 ( ) Older men (AGES) 2 Older women (AGES) 171 hip fx vs 877 control * Adjusted for age, race 3.7 ( ) 2.7 ( ) 3.5 ( ) 4.2 ( ) 1 Orwoll et al, JBMR 29; 2 Kopperdahl et al, JBMR Osteoporosis screening in IBD patients undergoing contrast-enhanced CT Enterography DXA t-score vs FEA fragile bone strength Osteoporosis R 2 =.84 Women Y Men Fragile Bone Strength Weber et al, Am J Gastroenterology, 214 Weber et al, Am J Gastroenterology, 214 9
10 Bone Strength DXA-based methods QCT, HR-QCT HR-pQCT Finite Element Analysis Reference point indentation SIZE & SHAPE how much? how is it arranged? BONE REMODELING formation / resorption? MATRIX PROPERTIES mineralization collagen traits Osteoporosis Drugs, Diet, Exercise, Diseases,. How do we assess bone material and tissue level mechanical properties? Assessing bone tissue level biomechanical properties with reference probe indentation Estimated elastic modulus ult. strength toughness elastic modulus ult. strength toughness elastic modulus hardness 2.5 µm Hansma et al 28, Hansma et al 29, Diez-Perez et al JBMR 21 Total Indentation Distance ( m) Age (years) Hip Fracture Control 1
11 Impact microindentation (Osteoprobe) Hand-held, portable 2.5 µm at tip of test probe Single impact indentation, anterior midtibia Reproducibility = 1.65% (Farr et al, JBMR 214) In vivo reference point indentation Bone Material Strength Index (BMSi) Indentation distance into subject s bone normalized by indentation distance into reference material Bridges et al, Rev Sci Instr 212 Randall et al, J Med Devices 212 Bone material strength index (BMSi) in clinical studies Diabetes 1 ~ 1% lower BMSi in postmenopausal women with longstanding T2D Fracture prediction 2 ~ 5% lower BMSi in those with prior hx of fragility fracture, independent of BMD Glucocorticoid-induced osteoporosis 3 BMSi declines after initiation of glucocorticoids 1 Farr et al, 214; 2 Malgo et al, 215; 3 Mellibovsky et al 215 Neuromuscular function Medications Environmental hazards Time spent at risk Fall direction, height Protective responses Energy absorption Lifting activity Bone mass Bone geom + µ-arch Bone matrix prop s Peak bone mass Risk of fall Force applied to bone magnitude, direction Rate of bone loss Bone strength Fracture? 11
12 Independent risk factors for hip fracture in fallers Independent risk factors for hip fracture in elderly fallers Factor Adjusted Odds Ratio Fall to side 5.7 (2.3-14) Femoral BMD 2.7 ( )* Fall energy 2.8 ( )** Body mass index 2.2 ( )* * calculated for a decrease of 1 SD ** calculated for an increase of 1 SD Factor Adjusted Odds Ratio Fall to side 5.7 (2.3-14) Femoral BMD 2.7 ( )* Fall energy 2.8 ( )** Body mass index 2.2 ( )* * calculated for a decrease of 1 SD ** calculated for an increase of 1 SD Greenspan et al, JAMA, 1994 Greenspan et al, JAMA, 1994 Trochanteric soft tissue thickness and hip fracture 644 women (129 hip fx); 1183 men (237 hip fx) Trochanteric soft tissue thickness: too little in men to make a difference? Odds Ratio for Hip Fracture (per 1 SD increase or decrease) Women Men Fem Neck BMD 2.36 (1.77, 3.15) ** 3.34 (2.65, 4.21) ** Fall force 1.67 (1.25, 2.25) ** 1.23 (1., 1.51) * Trochanteric Soft Tissue Thickness 1.79 (1.35, 2.37) ** 1.1 (.84, 1.23) * p <.5; ** p <.1 Framingham Osteoporosis Study, MrOS, and Rancho Bernardo Cohorts Trochanteric soft tissue thickness (mm) 12
13 Biomechanics of vertebral fractures Occurrence of vertebral fractures varies along the spine Vertebral fx are difficult to study Definition is controversial Many do not come to clinical attention Slow vs. acute onset The event that causes the fracture is often unknown Poor understanding of the relationship between spinal loading and vertebral fx T4 T6 T8 T1 T12 L2 L4 Relative fracture prevalence from European women and men over age 5 (Ismail et al, 1999) Estimating Loads on the Spine Muscle Strength & Quality Spinal Curvature Activity Loads applied to the vertebra Vertebral strength FRACTURE? Alex Bruno HST PhD candidate 13
14 Predicted Loads on Lumbar Spine for Activities of Daily Living Variation in vertebral loads and factor-of-risk peak 9 Compressive Load (N).18 Load: strength ratio Activity Load (% BW) Standing 51 Rise from chair 173 Stand, hold 8 kg, 23 arms extended Stand, flex trunk 3 o, 146 arms extended Lift 15 kg from floor 319 for a 162 cm, 57 kg woman Vertebral Compressive Loading (N) Vertebral Compressive Load (N) T1 T3 T5 T7 T9 T11 L1 L3 L T1 T3 T5 T7 T9 T11 L1 L3 L5 Factor-of-Risk Factor-of-risk T6 T8 T1 T12 L2 L TK =.2 TK = 26 TK = 5.1 TK = 74 T6 T8 T1 T12 L2 L4 Non-invasive assessment of bone strength: where are we today? A few techniques have recent FDA approval TBS may add to BMD predictions of fracture QCT-based FEA may expand number of individuals diagnosed Techniques are well suited for clinical research and clinical trials Pathophysiology & differentiate mechanism of action Our vision: a clinically relevant tool Bone strength estimates Improved fracture risk prediction? Patient specific loading estimates Not yet clear how to use in routine clinical practice QCT & FEA: No clear advantage over BMD for fx prediction Indentation -- early stage & many questions remain Examining non-bmd aspects of fracture risk (ie, loading) may provide important insights 14
15 NIH AR53986Funding Funding support: NIH R1 AR53986, R1 AR/AG41398, T32 AG2348, NHLBI Framingham Heart Study, and research grants from Amgen and Merck & Co. 15
Beyond BMD: Bone Quality and Bone Strength
Beyond BMD: Bone Quality and Bone Strength Mary L. Bouxsein, PhD Center for Advanced Orthopedic Studies Department of Orthopedic Surgery, Harvard Medical School MIT-Harvard Health Sciences and Technology
More informationImaging to Assess Bone Strength and its Determinants
Imaging to Assess Bone Strength and its Determinants Mary L. Bouxsein, PhD Harvard Medical School, Boston, MA UCSF Osteoporosis Course 26 July 212 Consultant / advisor: Amgen, Eli Lilly, Merck Research
More informationBeyond BMD: Bone Quality and Bone Strength
Beyond BMD: Bone Quality and Bone Strength Consultant / advisor: Amgen, Eli Lilly, Merck Disclosures Mary L. Bouxsein, PhD Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA mbouxsei@bidmc.harvard.edu
More informationBeyond BMD: Bone Quality and Bone Strength
Beyond BMD: Bone Quality and Bone Strength Consultant / advisor: Amgen, Eli Lilly, Merck Disclosures Mary L. Bouxsein, PhD Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA mbouxsei@bidmc.harvard.edu
More informationThis is a repository copy of Microarchitecture of bone predicts fractures in older women.
This is a repository copy of Microarchitecture of bone predicts fractures in older women. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/130351/ Version: Accepted Version
More informationAACE Congress Symposium Boston, MA May 20, 2018
Bone Loss After Bariatric Surgery: Causes, Consequences and Management John P. Bilezikian, MD, PhD(hon), MACE Silberberg Professor of Medicine Vice-Chair for International Education and Research Chief,
More informationInterpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm
Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis
More informationBIOLOGY and BIOMECHANICS OF NORMAL & OSTEOPOROTIC BONE
BIOLOGY and BIOMECHANICS OF NORMAL & OSTEOPOROTIC BONE Andreas Panagopoulos, MD, PhD Assistant Professor in Orthopaedics University Hospital of Patras, Orthopaedic Clinic Objectives Bone structure and
More informationBare Bones. Use of Systemic Osteoporosis Drugs in Select High Risk Patients Undergoing Spine Surgery
Use of Systemic Osteoporosis Drugs in Select High Risk Patients Undergoing Spine Surgery 30th Annual Metabolic Bone Disease Society Meeting Denver, CO Oct 11, 2018 Bare Bones 2000 Francesca Pera Kelly
More informationHRT and Risedronate Combined Anabolic and Antiresorptive Therapy
Optimizing Combined and Sequential Osteoanabolic and Antiresorptive Therapy Benjamin Leder, M.D. Endocrine Unit Massachusetts General Hospital Boston, MA Antiresorptive and Osteoanabolic Therapies Increase
More informationChapter 39: Exercise prescription in those with osteoporosis
Chapter 39: Exercise prescription in those with osteoporosis American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:
More informationFractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases
Financial Disclosures Fractures: Epidemiology and Risk Factors Research grants, speaking or consulting: Amgen, Lilly, Merck, Novartis, Radius Dennis M. Black, PhD Department of Epidemiology and Biostatistics
More informationCASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS
4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending
More information7/5/2016. We need drugs that. Disclosures. New Osteoporosis Treatments. What we have today. Maintain or promote bone formation
New Osteoporosis Treatments Disclosures Mary L. Bouxsein, PhD Department of Orthopedic Surgery Harvard Medical School, Boston, MA Advisory Board: Research funding: Merck, Eli Lilly, Radius Merck, Amgen
More informationOsteoporosis Screening and Treatment in Type 2 Diabetes
Osteoporosis Screening and Treatment in Type 2 Diabetes Ann Schwartz, PhD! Dept. of Epidemiology and Biostatistics! University of California San Francisco! October 2011! Presenter Disclosure Information
More informationOsteoporosis in Men Professor Peter R Ebeling
Osteoporosis in Men MD FRACP Head, Department of Medicine, School for Clinical Sciences Monash Health Translation Precinct Monash University, Clayton, Victoria 1 MonashHealth Potential Conflicts Departmental
More informationTrabecular Bone Score (TBS)
Trabecular Bone Score (TBS) From fracture prediction to clinical use Teheran May 2016 Prof. Didier Hans Center for Bone diseases, DAL Lausanne University Hospital, Switzerland didier.hans@ascendys.ch Osteoporosis
More informationChallenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA
Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationObjectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status.
Objectives Discuss bone health and the consequences of osteoporosis on patients medical and disability status. Discuss the pathophysiology of osteoporosis and major risk factors. Assess the major diagnostic
More informationThickness Computation Under In-Vivo Trabecular Bone CT Imaging
Thickness Computation Under In-Vivo Trabecular Bone CT Imaging Gokul. S PG Scholar,M.E - II year Department of Computer Science and Engineering Jansons Institute of Technology Coimbatore, Tamilnadu Aarthi.K
More informationBone Microarchitecture Assessed by HR-pQCT as Predictor of Fracture Risk in Postmenopausal Women: The OFELY Study
ORIGINAL ARTICLE JBMR Bone Microarchitecture Assessed by HR-pQCT as Predictor of Fracture Risk in Postmenopausal Women: The OFELY Study Elisabeth Sornay-Rendu, Stephanie Boutroy, FranScois Duboeuf, and
More informationDisclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014
Disclosures Diagnostic Challenges in Osteoporosis: Whom To Treat Ethel S. Siris, MD Columbia University Medical Center New York, NY Consultant on scientific issues for: AgNovos Amgen Eli Lilly Merck Novartis
More informationMeta-analysis: analysis:
1 Diabetes and TZDs: Risk Factors for Fracture Ann Schwartz, PhD Dept. of Epidemiology and Biostatistics University of California San Francisco July 2010 Osteoporosis CME Presenter Disclosure Information
More informationJuly 2012 CME (35 minutes) 7/12/2016
Financial Disclosures Epidemiology and Consequences of Fractures Advisory Board: Amgen Janssen Pharmaceuticals Inc. Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Osteoporotic
More informationIncreased Cortical Porosity in Older Men With Fracture
ORIGINAL ARTICLE JBMR Increased Cortical Porosity in Older Men With Fracture Daniel Sundh, 1,2 * Dan Mellstr om, 1,2 * Martin Nilsson, 1,2 Magnus Karlsson, 3 Claes Ohlsson, 2 and Mattias Lorentzon 1,2
More informationNew Dual-energy X-ray Absorptiometry Machines (idxa) and Vertebral Fracture Assessment
Case 1 New Dual-energy X-ray Absorptiometry Machines (idxa) and Vertebral Fracture Assessment (VFA) History and Examination Your wealthy friend who is a banker brings his 62-year-old mother to your office
More informationBuilding Bone Density-Research Issues
Building Bone Density-Research Issues Helping to Regain Bone Density QUESTION 1 What are the symptoms of Osteoporosis? Who is at risk? Symptoms Bone Fractures Osteoporosis 1,500,000 fractures a year Kyphosis
More informationOsteoporosis in older men is a major public health problem.
ORIGINAL ARTICLE JBMR Prediction of Fractures in Men Using Bone Microarchitectural Parameters Assessed by High-Resolution Peripheral Quantitative Computed Tomography The Prospective STRAMBO Study Pawel
More informationManaging the Patient with Osteoporosis Undergoing Spinal Surgery
11/4/16 DISCLOSURES Managing the Patient with Osteoporosis Undergoing Spinal Surgery MEDTRONIC LILLY MISONIX SHANE BURCH MD, MS, FRCSC Associate Professor in Residence UCSF Department of Orthopedic Surgery
More informationSKELETAL FRAGILITY AND FRACTURE RISK IN PATIENTS WITH DIABETES
SKELETAL FRAGILITY AND FRACTURE RISK IN PATIENTS WITH DIABETES Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Stock options/holdings, company owner, official role:
More informationAge changes in the human femoral neck and progression to failure. Functional Adaptation in the Femoral Neck
Age changes in the human femoral neck and progression to failure Functional Adaptation in the Femoral Neck Changes with Ageing Processes Associated with Structural Failure From the macroscopic to the microscopic
More informationOsteoporosis: A Tale of 3 Task Forces!
Osteoporosis: A Tale of 3 Task Forces! Robert A. Adler, MD McGuire Veterans Affairs Medical Center Virginia Commonwealth University Richmond, Virginia, USA Disclosures The opinions are those of the speaker
More informationNew Therapeutic Directions: Osteoanabolic and Antiresorptive Therapy in Combination Therapy and in Sequence
New Therapeutic Directions: Osteoanabolic and Antiresorptive Therapy in Combination Therapy and in Sequence John P. Bilezikian, MD, PhD(hon), MACE Silberberg Professor of Medicine Vice-Chair for International
More informationBone Investigational Toolkit BIT. Biomechanical Bone Integrity Assessment
Bone Investigational Toolkit BIT TM Biomechanical Bone Integrity Assessment The Bone Densitometry Problem Modeling of cortical shell failure with third-party engineering models. Bone densitometry is widely
More informationEpidemiology and Consequences of Fractures
Epidemiology and Consequences of Fractures Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Financial Disclosures Advisory Board: Amgen Research Support: Hologic 24July12 1 Outline
More informationCT Imaging of skeleton in small animals. Massimo Marenzana
CT Imaging of skeleton in small animals Massimo Marenzana Introduction Osteoporosis is a disease in which bones become fragile and more likely to break. It can be defined as a systemic skeletal disease
More informationDownload slides:
Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division
More informationDXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi
DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi Clinical Utility of Bone Densitometry Diagnosis (DXA)
More informationTeriparatide for osteoporosis: importance of the full course
Osteoporos Int (2016) 27:2395 2410 DOI 10.1007/s00198-016-3534-6 REVIEW Teriparatide for osteoporosis: importance of the full course R. Lindsay 1 & J. H. Krege 2 & F. Marin 3 & L. Jin 2 & J. J. Stepan
More informationUsing the FRAX Tool. Osteoporosis Definition
How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX
More informationFractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009
Fractures: Epidemiology and Risk Factors Mary L. Bouxsein, PhD Department of Orthopaedic Surgery Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA Outline Fracture incidence and impact
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationADOLESCENT OBESITY: IS IT BAD FOR THE BONES
ADOLESCENT OBESITY: IS IT BAD FOR THE BONES Babette S. Zemel, PhD Director, Nutrition And Growth Laboratory Division Of Gastroenterology, Hepatology And Nutrition The Children s Hospital Of Philadelphia
More informationRisk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study
Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study Heikki Kröger Kuopio Musculoskeletal Research Unit, University of Eastern Finland (UEF) Dept. of Orthopaedics, Traumatology
More informationOmnisense: At Least As Good As DXA
Omnisense: At Least As Good As DXA The following document summarizes a series of clinical studies that have been conducted to compare between different qualities of the Sunlight support the claim that
More informationMECHANICAL PROPERTIES OF A SINGLE CANCELLOUS BONE TRABECULAE TAKEN FROM BOVINE FEMUR
Advanced Materials Development and Performance (AMDP2011) International Journal of Modern Physics: Conference Series Vol. 6 (2012) 349-354 World Scientific Publishing Company DOI: 10.1142/S201019451200342X
More information8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview
Disclosure Glucocorticoid induced osteoporosis: overlooked and undertreated? I have no financial disclosure relevant to this presentation Tasma Harindhanavudhi, MD Division of Diabetes and Endocrinology
More informationSilvia Capuani*, Giulia Di Pietro*, Guglielmo Manenti, Umberto Tarantino^
Silvia Capuani*, Giulia Di Pietro*, Guglielmo Manenti, Umberto Tarantino^ *CNR ISC, Physics Department Sapienza University, Rome, Italy Department of Diagnostic Imaging and Interventional Radiology, Molecular
More informationCurrent and Emerging Strategies for Osteoporosis
Current and Emerging Strategies for Osteoporosis I have nothing to disclose. Anne Schafer, MD Assistant Professor of Medicine Division of Endocrinology & Metabolism December 12, 2014 Outline Osteoporosis
More informationTrabecular Bone Score (TBS) A Novel Method to Evaluate Bone Microarchitectural Texture in Patients With Primary Hyperparathyroidism
ORIGINAL ARTICLE Endocrine Care Trabecular Bone Score (TBS) A Novel Method to Evaluate Bone Microarchitectural Texture in Patients With Primary Hyperparathyroidism Barbara Campolina Silva, Stephanie Boutroy,
More informationDisclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck
Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence and impact of fractures
More informationLeast significant changes and monitoring time intervals for high-resolution pqct-derived bone outcomes in postmenopausal women
J Musculoskelet Neuronal Interact 2015; 15(2):190-196 Original Article Hylonome Least significant changes and monitoring time intervals for high-resolution pqct-derived bone outcomes in postmenopausal
More informationCIC Edizioni Internazionali. Bone quality and bone strength: benefits of the bone-forming approach. Mini-review
Bone quality and bone strength: benefits of the bone-forming approach Giovanni Iolascon Laura Frizzi Gioconda Di Pietro Annarita Capaldo Fabrizio Luciano Francesca Gimigliano Department of Medical and
More informationBone Mineral Densitometry with Dual Energy X-Ray Absorptiometry
Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry R Gilles, Laurentius Ziekenhuis Roermond 1. Introduction Osteoporosis is characterised by low bone mass, disruption of the micro-architecture
More informationOSTEOPOROSIS AND SARCOPENIA IN OLDER ADULTS. Didier Chalhoub. B.S. in Biology, American University of Beirut, Lebanon, 2007
OSTEOPOROSIS AND SARCOPENIA IN OLDER ADULTS by Didier Chalhoub B.S. in Biology, American University of Beirut, Lebanon, 2007 M.D., University of Balamand, Lebanon, 2011 M.P.H., University of Pittsburgh,
More informationObesity is a public health concern worldwide. If not rapidly. Bone Health After Bariatric Surgery REVIEW
REVIEW Bone Health After Surgery Claudia Gagnon 1,2,3,4 and Anne L Schafer 5,6,7 1 Department of Medicine, Universite Laval, Quebec City, Canada 2 Endocrinology and Nephrology Unit, CHU de Quebec Research
More informationMonitoring Osteoporosis Therapy
Monitoring Osteoporosis Therapy SUZANNE MORIN DEPT OF MEDICINE, DIVISION OF GENERAL INTERNAL MEDICINE, MUHC CENTRE FOR OUTCOMES RESEARCH AND EVALUATION, RI MUHC November 2017 Conflict of Interest Disclosures
More informationDifferentiating Pharmacological Therapies for Osteoporosis
Differentiating Pharmacological Therapies for Osteoporosis Socrates E Papapoulos Department of Endocrinology & Metabolic Diseases Leiden University Medical Center The Netherlands Competing interests: consulting/speaking
More informationTrabecular bone analysis with tomosynthesis in diabetic patients: comparison with CT-based finite-element method
Trabecular bone analysis with tomosynthesis in diabetic patients: comparison with CT-based finite-element method Poster No.: C-1789 Congress: ECR 2015 Type: Scientific Exhibit Authors: M. Fujii, T. Aoki,
More informationOSTEOPOROSIS, OSTEOARTHRITIS AND MUSKOSKELETAL DISEASE: A CALL FOR ACTION
V O L U M E 5 6 N U M B E R 2 J U N E 2 0 1 4 OSTEOPOROSIS, OSTEOARTHRITIS AND MUSKOSKELETAL DISEASE: A CALL FOR ACTION PANMINERVA MED 2014;56:97-114 J. Y., A. NEUPREZ, CH. BEAUDART, F. BUCKINX, J. SLOMIAN,
More informationUpcoming Agents for Osteoporosis
Upcoming Agents for Osteoporosis May 5, 2017 Michael R. McClung, MD, FACP Director, Oregon Osteoporosis Center Portland, Oregon, USA Professorial Fellow, Institute of Health and Ageing Australian Catholic
More informationS. N. Khan 1, R. M. Warkhedkar 2, A. Shyam 3, B. R. Patil 4
IOSR Journal of Mechanical and Civil Engineering (IOSR-JMCE) ISSN(e) : 2278-1684, ISSN(p) : 2320 334X, PP : 40-44 www.iosrjournals.org Correlation between BMD and Radio intensity of Human Bones for Strength
More informationNICE SCOOP OF THE DAY FRAX with NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield
NICE SCOOP OF THE DAY FRAX with NOGG Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield Disclosures Consultant/Advisor/Speaker for: o ActiveSignal, Amgen, AstraZeneca, Consilient
More informationBone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationTreatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014
Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays Suzanne Morin MD FRCP FACP McGill University May 2014 Learning Objectives Overview of osteoporosis management Outline efficacy
More informationDisclosures Fractures:
Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Research Funding: GlaxoSmithKline, Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence
More informationAccuracy of DEXA scanning & other methods for determining BMD.
BMD- Measurement Site Accuracy of DEXA scanning & other methods for determining BMD. Ann Larkin In general, densitometry techniques can be performed in either the axial or the appendicular skeleton, depending
More informationOSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO
OSTEOPOROSIS IN MEN Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Speakers Bureau: Amgen, Radius Consultant: Abbvie, Amgen, Janssen, Radius, Sanofi Watts NB et
More informationMen and Osteoporosis So you think that it can t happen to you
Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School
More information2013 ISCD Official Positions Adult
2013 ISCD Official Positions Adult These are the Official Positions of the ISCD as updated in 2013. The Official Positions that are new or revised since 2007 are in bold type. Indications for Bone Mineral
More informationLearning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.
12:45 1:30pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn
More informationNanoindentation of trabecular bone in human vertebrae classified as normal, osteopenic and osteoporotic by ultrasonometry of the calcaneus
Nanoindentation of trabecular bone in human vertebrae classified as normal, osteopenic and osteoporotic by ultrasonometry of the calcaneus The evaloution of microarchitecture resistance of the trabecular
More informationAnabolic Therapy With Teriparatide Indications Beyond Osteoporosis
Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis Andreas Panagopoulos MD, PhD Upper Limb & Sports Medicine Orthopaedic Surgeon Assistant Professor, University of Patras Outline Teriparatide
More informationControversies in Osteoporosis Management
Controversies in Osteoporosis Management 2018 Northwest Rheumatism Society Meeting Portland, OR April 28, 2018 Michael R. McClung, MD, FACP Director, Oregon Osteoporosis Center Portland, Oregon, USA Institute
More informationEvaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women
ORIGINAL ARTICLE JBMR Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women Emmanuel Biver, 1 Claire Durosier-Izart, 1 Thierry Chevalley,
More informationForteo (teriparatide) Prior Authorization Program Summary
Forteo (teriparatide) Prior Authorization Program Summary FDA APPROVED INDICATIONS DOSAGE 1 FDA Indication 1 : Forteo (teriparatide) is indicated for: the treatment of postmenopausal women with osteoporosis
More informationBONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis
BONE HEALTH Dr. Tia Lillie Exercise, Physical Activity and Osteoporosis Food for thought... How old would you be if you didn t know how old you were? DEFINITION: Osteoporosis Osteoporosis (OP) is a disease
More informationLUMBAR IS IT IMPORTANT? S. Tantawy,, M.D.
بسم االله الرحمن الرحيم DEXA LATERAL LUMBAR IS IT IMPORTANT? By S. Tantawy,, M.D. Osteopenia,, bone mineral deficiency in the absence of fracture, is an indicator of the bone structural integrity and compared
More informationAbaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24- week randomized clinical trial
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24- week randomized clinical trial The Harvard community has made this article openly available. Please
More informationHHS Public Access Author manuscript Endocr Pract. Author manuscript; available in PMC 2017 April 10.
BEYOND DXA: ADVANCES IN CLINICAL APPLICATIONS OF NEW BONE IMAGING TECHNOLOGY Monika Pawlowska, MD, FRCPC 1 and John P. Bilezikian, MD, MACE 2 1 Division of Endocrinology, Department of Medicine, University
More informationThe Harvard community has made this article openly available. Please share how this access benefits you. Your story matters
Mechanical Contributions of the Cortical and Trabecular Compartments Contribute to Differences in Age- Related Changes in Vertebral Body Strength in Men and Women Assessed by QCT-Based Finite Element Analysis
More informationIn women who have not been on prior osteoporosis
CLINICAL TRIALS JBMR Hip and Spine Strength Effects of Adding Versus Switching to Teriparatide in Postmenopausal Women With Osteoporosis Treated With Prior Alendronate or Raloxifene Felicia Cosman, 1,2
More informationModule 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC
Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with
More informationOsteoporosis/Fracture Prevention
Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team
More informationBone Strength Estimated by Micro-Finite Element Analysis (mfea) Is Heritable and Shares Genetic Predisposition With Areal BMD: The Framingham Study
ORIGINAL ARTICLE JBMR Bone Strength Estimated by Micro-Finite Element Analysis (mfea) Is Heritable and Shares Genetic Predisposition With Areal BMD: The Framingham Study David Karasik, 1,2 Serkalem Demissie,
More informationBad to the Bones: Diabetes and Thiazolidinediones 9/9/2010. Steven Ing, MD, MSCE Assistant Professor Division of Endocrinology, Diabetes & Metabolism
Bad to the Bones: Diabetes and Thiazolidinediones 9/9/2010 Steven Ing, MD, MSCE Assistant Professor Division of Endocrinology, Diabetes & Metabolism Any reduction of bone mass in diabetics that is revealed
More informationOutline. Estrogens and SERMS The forgotten few! How Does Estrogen Work in Bone? Its Complex!!! 6/14/2013
Outline Estrogens and SERMS The forgotten few! Clifford J Rosen MD rosenc@mmc.org Physiology of Estrogen and estrogen receptors Actions of estrogen on bone BMD, fracture, other off target effects Cohort
More informationComparison of in Vitro Young and Old Lumbar Vertebrae of Ewes Related to Bone Density and Compression Strength
Modern Applied Science; Vol. 11, No. 4; 2017 ISSN 1913-1844 E-ISSN 1913-1852 Published by Canadian Center of Science and Education Comparison of in Vitro Young and Old Lumbar Vertebrae of Ewes Related
More informationBone microarchitecture is a determinant of bone strength
ORIGINAL ARTICLE JBMR Microarchitecture and Peripheral BMD are Impaired in Postmenopausal White Women With Fracture Independently of Total Hip T-Score: An International Multicenter Study Stephanie Boutroy,
More information# % # & # # ( # ) # % # # ) +,#. # ) / ) 3 ) ) 7 55, # 09 /:2 ;88% 111 <!= <01 9<1:<:1:==
! # % # & # # ( # ) # % # # ) +,#. # ) /01 2 + ) 3 ) 4 5 6 ) 7 55, 5 8 3 # 09 /:2 ;88% 111 This is the accepted version of the following article: Joshua N. Farr, Wei Zhang, Shaji
More informationAnalysis of Clinical Features of Hip Fracture Patients with or without Prior Osteoporotic Spinal Compression Fractures
J Bone Metab 2013;20:11-15 http://dx.doi.org/10.11005/jbm.2013.20.1.11 pissn 2287-6375 eissn 2287-7029 Original Article Analysis of Clinical Features of Hip Fracture Patients with or without Prior Osteoporotic
More informationCurrent Issues in Osteoporosis
Current Issues in Osteoporosis California AACE 18TH Annual Meeting & Symposium Marina del Rey, CA September 15, 2018 Michael R. McClung, MD, FACP,FACE Director, Oregon Osteoporosis Center Portland, Oregon,
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF NEW MEDICINAL PRODUCTS IN THE TREATMENT OF PRIMARY OSTEOPOROSIS
European Medicines Agency Evaluation of Medicines for Human Use London, 14 December 2005 Doc. Ref. CPMP/EWP/552/95 Rev. 2 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON THE EVALUATION
More informationOsteoporosis Update. Case 2. Case 1: Monday morning, 8:15
Osteoporosis Update Laura E. Ryan, MD Assistant Director for Special Programs Center for Women s Health Clinical Assistant Professor of Medicine Division of Endocrinology, Diabetes and Metabolism The Ohio
More informationSpongeBone Menopants*
SpongeBone Menopants* Adam Fershko, MD, FACP Kettering Health Network *Postmenopausal Osteoporosis Objectives O Epidemiology O Clinical significance O Pathophysiology O Screening and Diagnosis O Treatment
More informationAbstract. Introduction
Microstructural Parameters of Bone Evaluated Using HRpQCT Correlate with the DXA-Derived Cortical Index and the Trabecular Bone Score in a Cohort of Randomly Selected Premenopausal Women Albrecht W. Popp
More informationPrevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p.
Dedication Preface Acknowledgments Continuing Education An Introduction to Conventions in Densitometry p. 1 Densitometry as a Quantitative Measurement Technique p. 2 Accuracy and Precision p. 2 The Skeleton
More information